|Title:||Treatment for basal cell carcinoma|
|Abstract:||The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.|
|Inventor(s):||Owens; Mary L. (Cottage Grove, MN), Fox; Terrance L. (Oakdale, MN), Ginkel; Angela M. (St. Paul, MN)|
|Assignee:||Graceway Pharmaceuticals, LLC (Bristol, TN)|
Patent Claim Types:|
see list of patent claims
Field: Basic materials chemistry
Back Citations: 101st percentile
Forward Citations: 23rd percentile
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|CREAM;TOPICAL||020723-001||Feb 27, 1997||RX||Yes||Yes||7,696,159*PED||► subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.